Dr. Wall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Medical Park Dr
Ste 110
Concord, NC 28025Phone+1 704-403-6826Fax+1 704-403-1389
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1985 - 1988- National Capital ConsortiumResidency, Internal Medicine, 1982 - 1985
University of North Carolina at Chapel Hill School of MedicineClass of 1982
Certifications & Licensure
NC State Medical License 1986 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Modular EHR, Cerner Corporation, 2013
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- Cytogenetic Studies in Acute Leukemia and Multiple Myeloma Start of enrollment: 1984 Jun 01
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsEltrombopag-Associated Acneiform Rash: A Case Report.Amani M Cobert, James G Wall, Donald C Moore
American Journal of Therapeutics. 2021-03-01 - 19 citationsUse of the blood substitute HBOC‐201 in critically ill patients during sickle crisis: a three‐case seriesJonathan M. Davis, Nura El-Haj, Nimish Shah, Garry Schwartz, Margaret Block
Transfusion. 2018-01-01 - 46 citationsA Phase II trial of Bendamustine in combination with Rituximab in older patients with previously untreated Diffuse Large B-Cell LymphomaSteven I. Park, Natalie S Grover, Oludamilola Olajide, Adam S. Asch, James G. Wall
British Journal of Haematology. 2016-10-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
